Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

ClinicalTrials.gov ID: NCT01788046

Public ClinicalTrials.gov record NCT01788046. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to assess the efficacy and safety of etelcalcetide (AMG 416) compared with placebo in the treatment of SHPT in CKD patients receiving hemodialysis.

Study identification

NCT ID
NCT01788046
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
515 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 12, 2013 (Actual)
Primary completion
Apr 14, 2014 (Actual)
Completion
May 9, 2014 (Actual)
Last update posted
Aug 20, 2019

2013 – 2014

United States locations

U.S. sites
45
U.S. states
25
U.S. cities
45
Facility City State ZIP Site status
Research Site Mobile Alabama 36608 —
Research Site Azusa California 91702 —
Research Site Beverly Hills California 90211 —
Research Site Chula Vista California 91910 —
Research Site Fairfield California 94534 —
Research Site Glendale California 91205 —
Research Site Los Angeles California 90022 —
Research Site Northridge California 91324 —
Research Site Norwalk California 90650 —
Research Site Riverside California 92501 —
Research Site Simi Valley California 93065 —
Research Site Denver Colorado 80230 —
Research Site Stamford Connecticut 06902 —
Research Site Lauderdale Lakes Florida 33313 —
Research Site Miami Florida 33173 —
Research Site Ocala Florida 34471 —
Research Site Augusta Georgia 30901 —
Research Site Macon Georgia 31217 —
Research Site Chicago Illinois 60616 —
Research Site Gurnee Illinois 60031 —
Research Site Merrillville Indiana 46410 —
Research Site Wichita Kansas 67214-2998 —
Research Site Shreveport Louisiana 71101 —
Research Site Bethesda Maryland 20817 —
Research Site Ft. Washington Maryland 20744 —
Research Site Detroit Michigan 48202 —
Research Site Brookhaven Mississippi 39601 —
Research Site Lincoln Nebraska 68510 —
Research Site Las Vegas Nevada 89106 —
Research Site Eatontown New Jersey 07724 —
Research Site Brooklyn New York 11212 —
Research Site Fresh Meadows New York 11365 —
Research Site Great Neck New York 11021 —
Research Site Charlotte North Carolina 28207 —
Research Site New Bern North Carolina 28562 —
Research Site Cincinnati Ohio 45206 —
Research Site Columbia South Carolina 29203 —
Research Site Chattanooga Tennessee 37408 —
Research Site Knoxville Tennessee 37923 —
Research Site Arlington Texas 76015 —
Research Site Houston Texas 77054 —
Research Site Lubbock Texas 79430 —
Research Site Rutland Vermont 05701 —
Research Site Alexandria Virginia 22304 —
Research Site Morgantown West Virginia 26506-9165 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01788046, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01788046 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →